Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

Estimated reading time for CME/CPD: 2 mins

Impact of co-occurring maternal nicotine use, depression, and anxiety on perinatal outcomes

AI Summary
  • Combined nicotine use with depression and anxiety doubled severe maternal morbidity risk (adjusted RR 2.20).
  • Combined nicotine, depression, and anxiety significantly increased infant death, respiratory distress syndrome, and hypoglycaemia risks.
  • Anxiety, alone or with depression or nicotine, was associated with higher hypertensive disease of pregnancy (about 15% versus 7.7% reference).
Summarise with AI (MRCPsych/FRANZCP)

Pregnancy (Hoboken). 2026 Nov 18;2(6):e70505. doi: 10.1002/pmf2.70505. eCollection 2026 Nov.

ABSTRACT

INTRODUCTION: Nicotine is the most commonly used substance in pregnancy, and the prevalence of mental health disorders in pregnancy is rising. In this study, we analyzed the association of nicotine use and depression and/or anxiety disorders, separately and together, on perinatal outcomes, an understudied area.

METHODS: Retrospective cohort study using California linked vital statistics and hospital discharge data (2008-2020). Patients were categorized into eight categories: (1) no nicotine use or depression or anxiety (reference), (2) nicotine use only, (3) depression only, (4) anxiety only, (5) depression and anxiety, (6) nicotine use and depression, (7) nicotine use and anxiety, and (8) nicotine use with depression and anxiety. The maternal outcomes measured were hypertensive disease of pregnancy, preterm delivery <37 and <32 weeks, severe maternal morbidity (SMM), and non-transfusion SMM; while the neonatal outcomes were neonatal intensive care unit (NICU) admission, small for gestational age (SGA), respiratory distress syndrome (RDS), infant deaths, and hypoglycemia. We included 4,897,855 singleton, non-anomalous gestations delivered between 23 and 42 weeks and excluded individuals using other substances or diagnosed with bipolar disorder. Results were analyzed by chi-square tests and multivariable Poisson regression models.

RESULTS: Of the pregnant individuals included in this study, nicotine use was present in 1.4%, depression alone in 1.1%, anxiety alone in 1.2%, and combined depression and anxiety in 1.2%. Among maternal outcomes, SMM demonstrated a statistically significant association with combined nicotine use, depression, and anxiety (adjusted risk ratio [aRR], 2.20 [1.29-3.75]). Hypertensive disease was higher in groups with anxiety: only anxiety (15.3%), depression and anxiety (15.4%), and nicotine and anxiety (15.4%) compared to the reference group (7.7%). Among neonatal outcomes, infant death (aRR, 3.96 [1.66-9.46]), RDS (aRR, 2.03 [1.20-3.43]), and hypoglycemia (aRR, 1.67 [1.82-3.92]) were each significantly associated with combined nicotine use, depression, and anxiety. No other statistically significant increase in groups with nicotine use, depression, and anxiety were found in the other outcomes measured across the statistical analyses used.

CONCLUSION: Nicotine and depression/anxiety combined was associated with a higher risk of SMM, RDS, hypoglycemia, and infant death than each alone. These data can inform mechanistic research into the interaction between nicotine and mental health on perinatal outcomes.

PMID:43054555 | PMC:PMC13779564 | DOI:10.1002/pmf2.70505

Document this CPD

Share Evidence Blueprint

QR Code

Save to Google Notes

Search Google Scholar

⭐ My Revision List

close chatgpt icon
ChatGPT

Enter your request.

← →
RAISR4D CME/CPD Evidence Nodes
Swipe to navigate RAISR4D CME/CPD evidence nodes.
CME/CPD